Redx Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Redx Pharma generated cash of -$34,747,000, which is less than the previous year. Cash used in financing activities reached the amount of -$816,000 last year. Net change in cash is therefore -$35,762,000.
Cash Flow
| 2014 | -2.46M | -54K | 4.38M |
|---|---|---|---|
| 2015 | -6.53M | -362K | 13.44M |
| 2016 | -12.50M | -442K | 9.27M |
| 2017 | 14.09M | -30K | 3.98M |
| 2018 | -17.17M | -109K | -49K |
| 2019 | -4.66M | 32K | 1.86M |
| 2020 | 395K | -55K | 23.46M |
| 2021 | -21.37M | -754K | 24.14M |
| 2022 | -8.47M | -241K | 32.98M |
| 2023 | -34.74M | -195K | -816K |
REDX.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 53.85M | 29.55M | 27.51M | 3.70M | 6.47M | 23.80M | 5.75M | 9.43M | 2.89M | 1.02M |
Operating activities | ||||||||||
Net income | -33.15M | -18.00M | -21.57M | -9.21M | -4.31M | -8.84M | 1.52M | -15.52M | -8.17M | -4.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 960K | 886K | 633K | 665K | 91K | 164K | 327K | 262K | 139K | 252K |
Stock-based compensation expense | 3.19M | 4.36M | 3.78M | 568K | 45K | 0 | 13K | 245K | 608K | 14K |
| Deferred income tax benefit | 3.19M | 4.36M | 3.78M | 568K | 45K | 0 | 13K | 245K | 608K | 14K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 7.63M | -4.65M | -905K | 446K | 572K | -1.18M | -124K | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21K |
Accounts payable | 0 | -5.59M | -1.41M | 7.33M | -711K | -8.96M | 8.87M | 1.27M | 0 | 0 |
Cash generated by operating activities | -34.74M | -8.47M | -21.37M | 395K | -4.66M | -17.17M | 14.09M | -12.50M | -6.53M | -2.46M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -195K | -262K | -754K | -59K | -28K | -132K | -154K | -444K | -362K | -54K |
Acquisitions Net | 0 | 21K | 0 | 4K | 60K | 23K | 124K | 2K | 0 | 0 |
Cash generated by investing activities | -195K | -241K | -754K | -55K | 32K | -109K | -30K | -442K | -362K | -54K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 34.56M | 25.98M | 2.09M | 0 | 0 | 12.36M | 10M | 13.44M | 4.38M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -5M | 0 | 0 | 0 | -25K | 0 | 0 |
Cash used in financing activities | -816K | 32.98M | 24.14M | 23.46M | 1.86M | -49K | 3.98M | 9.27M | 13.44M | 4.38M |
Net Change In Cash | -35.76M | 24.30M | 2.03M | 23.80M | -2.76M | -17.33M | 18.04M | -3.67M | 6.54M | 1.86M |
Cash at end of period | 18.09M | 53.85M | 29.55M | 27.51M | 3.70M | 6.47M | 23.80M | 5.75M | 9.43M | 2.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |